Awakn Life Sciences Appoints Addiction Expert Prof. David Nutt as Chief Research Officer

Prof. Nutt Will Drive Progression of a Pipeline of New Psychedelic Medicines, Helping to Define a Clear Development Pathway to Treat Addiction Through Psychedelic Medicines